GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00464863 | Liver | NAFLD | glycerolipid metabolic process | 66/1882 | 392/18723 | 1.94e-05 | 5.52e-04 | 66 |
GO:00450174 | Liver | NAFLD | glycerolipid biosynthetic process | 43/1882 | 252/18723 | 3.83e-04 | 5.73e-03 | 43 |
GO:00464742 | Liver | NAFLD | glycerophospholipid biosynthetic process | 33/1882 | 211/18723 | 6.93e-03 | 4.88e-02 | 33 |
GO:00086542 | Liver | HCC | phospholipid biosynthetic process | 150/7958 | 253/18723 | 4.77e-08 | 1.03e-06 | 150 |
GO:00066444 | Liver | HCC | phospholipid metabolic process | 214/7958 | 383/18723 | 7.25e-08 | 1.48e-06 | 214 |
GO:004648611 | Liver | HCC | glycerolipid metabolic process | 215/7958 | 392/18723 | 4.54e-07 | 7.49e-06 | 215 |
GO:004501711 | Liver | HCC | glycerolipid biosynthetic process | 143/7958 | 252/18723 | 3.27e-06 | 4.31e-05 | 143 |
GO:00066504 | Liver | HCC | glycerophospholipid metabolic process | 168/7958 | 306/18723 | 7.27e-06 | 8.62e-05 | 168 |
GO:004647411 | Liver | HCC | glycerophospholipid biosynthetic process | 121/7958 | 211/18723 | 9.12e-06 | 1.06e-04 | 121 |
GO:0006661 | Liver | HCC | phosphatidylinositol biosynthetic process | 69/7958 | 131/18723 | 1.19e-02 | 4.35e-02 | 69 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SOCS7 | SNV | Missense_Mutation | novel | c.1088G>C | p.Arg363Pro | p.R363P | O14512 | protein_coding | deleterious(0) | possibly_damaging(0.737) | TCGA-BH-A0HY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | taxotere | CR |
SOCS7 | SNV | Missense_Mutation | novel | c.1033N>A | p.Pro345Thr | p.P345T | O14512 | protein_coding | deleterious_low_confidence(0.04) | possibly_damaging(0.879) | TCGA-D8-A1X9-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | adriamycin+cyclophosphamide | SD |
SOCS7 | insertion | Frame_Shift_Ins | novel | c.1136_1137insACTTAAGAAACTG | p.Tyr381LysfsTer8 | p.Y381Kfs*8 | O14512 | protein_coding | | | TCGA-AN-A0FX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SOCS7 | insertion | Frame_Shift_Ins | novel | c.1139_1140insTAATTTCAGGATAGTGAGGTTTAAT | p.Tyr381AsnfsTer12 | p.Y381Nfs*12 | O14512 | protein_coding | | | TCGA-AN-A0FX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SOCS7 | SNV | Missense_Mutation | novel | c.1589N>C | p.Val530Ala | p.V530A | O14512 | protein_coding | deleterious(0.01) | probably_damaging(0.992) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SOCS7 | SNV | Missense_Mutation | novel | c.1036N>T | p.Pro346Ser | p.P346S | O14512 | protein_coding | tolerated(0.21) | possibly_damaging(0.796) | TCGA-IR-A3LA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SOCS7 | SNV | Missense_Mutation | novel | c.1329C>G | p.Ile443Met | p.I443M | O14512 | protein_coding | tolerated(0.07) | possibly_damaging(0.905) | TCGA-MA-AA42-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
SOCS7 | SNV | Missense_Mutation | novel | c.454C>A | p.Leu152Met | p.L152M | O14512 | protein_coding | deleterious_low_confidence(0.02) | benign(0.367) | TCGA-F4-6570-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SOCS7 | SNV | Missense_Mutation | novel | c.1445N>G | p.Ser482Cys | p.S482C | O14512 | protein_coding | tolerated(0.06) | probably_damaging(0.999) | TCGA-A5-A0VP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SOCS7 | SNV | Missense_Mutation | novel | c.1591A>G | p.Arg531Gly | p.R531G | O14512 | protein_coding | deleterious(0.01) | probably_damaging(0.989) | TCGA-AJ-A2QO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |